Tradestie Institutional Equity Comparison Engine

SRTM vs NIVF โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SRTM Overall Edge

SRTM Captures Institutional Edge (2โ€“1 Pillars ยท 2โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SRTM (SRTM) driven by superior Momentum & Technical, Options & Structure while NIVF counters with relative strength in Growth & Margin. Fundamentally, SRTM trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus NIVF at N/M Forward P/E and -238.2% operating margin (-4.7% YoY). In options structure, SRTM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NIVF sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
SRTM N/M vs NIVF N/M Fwd P/E
Growth & Margin Winner NIVF
Op Margin N/A vs -238.2% ยท YoY N/A vs -4.7%
Momentum & Technical Winner SRTM
1Y -86.8% vs -91.8% ยท 52W Pos 2% vs 0%
Options & Structure Winner SRTM
UNCLASSIFIED (N/A IV) vs BREAKDOWN (N/A IV)
SRTM US Equity
SRTM
Institutional Equity
$0.08
-14.59% 1D
Market Cap N/A
1M Return -80.4%
1Y Return -86.83%
Forward P/E N/M
Unified AI Score
47.6 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
NIVF NASDAQ
NewGenIvf Group Limited Class A ordinary shares
Services-Misc Health & Allied Services, Nec
$0.03
-23.14% 1D
Market Cap $98,000
1M Return -81.93%
1Y Return -91.82%
Forward P/E N/M
Unified AI Score
47.7 / 100 HOLD
Tech 43.0 Fund 49.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SRTM -86.83% NIVF -91.82% Spread: +3.67 pp (SRTM Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SRTM TTM Op. Margin: N/A NIVF TTM Op. Margin: -238.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SRTM vs NIVF. Trailing 12-month operating profitability (SRTM N/A vs NIVF -238.2%) and valuation multiples (SRTM N/M vs NIVF N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SRTM (2) vs NIVF (5)
Institutional Metric SRTM NIVF Criterion Row Winner
Market Capitalization Scale N/A $98,000 Larger Scale NIVF
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A -4.7% Higher Growth NIVF
Operating Margin (TTM) Profitability N/A -238.2% Higher Margin NIVF
Net Profit Margin Profitability N/A 24.2% Higher Margin NIVF
Return on Equity (ROE) Capital Efficiency N/A 5.5% Higher ROE NIVF
52-Week Range Position Momentum 2% ($0โ€“$1) 0% ($0โ€“$3) Stronger Trend SRTM
Beta / 30D Volatility Risk Regime N/A 0.05ฮฒ ยท 3040% Vol Lower Realized Risk SRTM
Unified Institutional Score Composite Signal 47.6 / 100 (HOLD) 47.7 / 100 (HOLD) Higher Composite Tie

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SRTM vs NIVF Buy Guide
SRTM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SRTM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NIVF BREAKDOWN
19d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NIVF Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SRTM nor NIVF registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.